ELI LILLY & Co is 157.6x more valuable than Protagonist Therapeutics, Inc by market capitalization ($1.072 T vs $6.80 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTGX | LLY |
|---|---|---|
| Market cap | $6.80 B | $1.072 T |
| US-listed rank | #1171 | #10 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$130.15M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 668 | 989 |
ELI LILLY & Co is 157.6x more valuable than Protagonist Therapeutics, Inc by market capitalization ($1.072 T vs $6.80 B).
Full pages: Protagonist Therapeutics, Inc and ELI LILLY & Co, or browse the full rankings.